PHA Phase III valdecoxib data

Pharmacia (PHA) reported data from 2 double-blind, placebo-controlled Phase III trials, in which its valdecoxib COX-2 inhibitor had similar efficacy to naproxen in patients with osteoarthritis (OA) an...